STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 108 filers reported holding STOKE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71,913 | -62.9% | 18,252 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $194,019 | +127544.1% | 18,252 | +0.3% | 0.00% | 0.0% |
| Q1 2023 | $152 | -10.1% | 18,199 | -0.6% | 0.00% | -33.3% |
| Q4 2022 | $169 | -99.9% | 18,313 | 0.0% | 0.00% | -40.0% |
| Q3 2022 | $235,000 | +8.3% | 18,313 | +11.5% | 0.01% | -16.7% |
| Q2 2022 | $217,000 | -41.2% | 16,424 | -6.3% | 0.01% | -33.3% |
| Q1 2022 | $369,000 | -21.0% | 17,519 | -10.1% | 0.01% | +12.5% |
| Q4 2021 | $467,000 | +113.2% | 19,477 | +159.7% | 0.01% | +33.3% |
| Q2 2019 | $219,000 | – | 7,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 16,786,713 | $562,187,000 | 75.80% |
| RTW INVESTMENTS, LP | 3,544,248 | $118,697,000 | 2.86% |
| Cormorant Asset Management, LP | 1,537,807 | $51,501,000 | 1.98% |
| Redmile Group, LLC | 2,549,506 | $85,383,000 | 1.57% |
| Birchview Capital, LP | 40,000 | $1,340,000 | 0.45% |
| HighVista Strategies LLC | 17,082 | $572,000 | 0.42% |
| Perceptive Advisors | 671,978 | $22,505,000 | 0.33% |
| GILDER GAGNON HOWE & CO LLC | 1,490,153 | $49,905,000 | 0.31% |
| Artal Group S.A. | 270,750 | $9,067,000 | 0.22% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 323 | $11,000 | 0.20% |